Views & Analysis Living with DMD: Inspiring each other’s futures Diagnosed with Duchenne muscular dystrophy (DMD) at three years old, Dr Jon Hastie grew up n
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
